Published in J Neurosci on July 08, 2009
Synaptic dysfunction in depression: potential therapeutic targets. Science (2012) 3.15
Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci (2012) 1.90
Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology (2011) 1.85
Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol Psychiatry (2011) 1.77
AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future. Neuron (2010) 1.68
Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity. Pharmacol Ther (2009) 1.63
Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond. Neuropsychopharmacology (2011) 1.30
Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ (2012) 1.27
Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants. Biol Psychiatry (2013) 1.26
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med (2016) 1.26
Brain excitability in stroke: the yin and yang of stroke progression. Arch Neurol (2011) 1.16
Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections. Dialogues Clin Neurosci (2014) 1.15
Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties. Mol Psychiatry (2013) 1.12
BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol (2014) 1.08
Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health. Ann N Y Acad Sci (2012) 1.05
BDNF regulates atypical PKC at spinal synapses to initiate and maintain a centralized chronic pain state. Mol Pain (2013) 1.03
Calpain-2-mediated PTEN degradation contributes to BDNF-induced stimulation of dendritic protein synthesis. J Neurosci (2013) 1.02
A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos Trans R Soc Lond B Biol Sci (2012) 1.02
Cell atrophy and loss in depression: reversal by antidepressant treatment. Curr Opin Cell Biol (2011) 1.01
Rapid antidepressant effects: moving right along. Mol Psychiatry (2013) 0.93
BDNF - a key transducer of antidepressant effects. Neuropharmacology (2015) 0.93
Synaptic regulation of affective behaviors; role of BDNF. Neuropharmacology (2013) 0.89
Activity-dependent rapid local RhoA synthesis is required for hippocampal synaptic plasticity. J Neurosci (2015) 0.89
BDNF contributes to both rapid and homeostatic alterations in AMPA receptor surface expression in nucleus accumbens medium spiny neurons. Eur J Neurosci (2014) 0.85
Learning and memory: an emergent property of cell motility. Neurobiol Learn Mem (2013) 0.84
Therapeutic modalities for treatment resistant depression: focus on vagal nerve stimulation and ketamine. Clin Psychopharmacol Neurosci (2014) 0.83
A novel form of synaptic plasticity in field CA3 of hippocampus requires GPER1 activation and BDNF release. J Cell Biol (2015) 0.83
Multistage drug effects of ketamine in the treatment of major depression. Eur Arch Psychiatry Clin Neurosci (2014) 0.82
New targets for rapid antidepressant action. Prog Neurobiol (2015) 0.81
Neuropeptide cycloprolylglycine increases the levels of brain-derived neurotrophic factor in neuronal cells. Dokl Biochem Biophys (2016) 0.81
Brain-derived neurotrophic factor and addiction: Pathological versus therapeutic effects on drug seeking. Brain Res (2014) 0.79
Acute BDNF treatment upregulates GluR1-SAP97 and GluR2-GRIP1 interactions: implications for sustained AMPA receptor expression. PLoS One (2013) 0.78
Neuronal correlates of depression. Cell Mol Life Sci (2015) 0.77
Potential therapeutic approaches for Angelman syndrome. Expert Opin Ther Targets (2015) 0.77
Transcript specificity in BDNF-regulated protein synthesis. Neuropharmacology (2013) 0.76
Multi-level control of ionotropic glutamate receptor function. Cellscience (2009) 0.75
Ketamine produces antidepressant-like effects through phosphorylation-dependent nuclear export of histone deacetylase 5 (HDAC5) in rats. Proc Natl Acad Sci U S A (2015) 0.75
Milnacipran remediates impulsive deficits in rats with lesions of the ventromedial prefrontal cortex. Int J Neuropsychopharmacol (2014) 0.75
Timosaponin derivative YY-23 acts as a non-competitive NMDA receptor antagonist and exerts a rapid antidepressant-like effect in mice. Acta Pharmacol Sin (2015) 0.75
Exercise increases mTOR signaling in brain regions involved in cognition and emotional behavior. Behav Brain Res (2017) 0.75
Neuroplasticity and Repair in Rodent Neurotoxic Models of Spinal Motoneuron Disease. Neural Plast (2016) 0.75
Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms. Chronic Stress (Thousand Oaks) (2017) 0.75
Neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors. Dokl Biochem Biophys (2017) 0.75
Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine. Biol Psychiatry (2017) 0.75
Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science (2000) 7.86
Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science (2000) 5.28
Protein synthesis and memory: a review. Psychol Bull (1984) 5.26
Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science (1994) 5.21
Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis. Cell (2006) 4.35
Dynamic visualization of local protein synthesis in hippocampal neurons. Neuron (2001) 4.14
Glutamate receptor dynamics in dendritic microdomains. Neuron (2008) 3.28
The immediate early gene arc/arg3.1: regulation, mechanisms, and function. J Neurosci (2008) 2.73
The 3'-untranslated region of CaMKII alpha is a cis-acting signal for the localization and translation of mRNA in dendrites. Proc Natl Acad Sci U S A (1996) 2.70
Brain-derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus. J Neurosci (2007) 2.39
Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J Neurosci (2004) 2.29
Postsynaptic translation affects the efficacy and morphology of neuromuscular junctions. Nature (2000) 2.29
Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron (2002) 2.03
A developmental switch of AMPA receptor subunits in neocortical pyramidal neurons. J Neurosci (2002) 1.86
Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J Biol Chem (2006) 1.77
The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes. Proc Natl Acad Sci U S A (2002) 1.66
Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. Curr Drug Targets (2007) 1.64
Activity bidirectionally regulates AMPA receptor mRNA abundance in dendrites of hippocampal neurons. J Neurosci (2006) 1.60
Natural patterns of activity and long-term synaptic plasticity. Curr Opin Neurobiol (2000) 1.58
Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. J Neurosci (2000) 1.58
Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J Neurosci (2007) 1.52
Brain-derived neurotrophic factor enhances long-term potentiation in rat visual cortex. J Neurosci (1997) 1.52
TrkB kinase is required for recovery, but not loss, of cortical responses following monocular deprivation. Nat Neurosci (2008) 1.50
Local synthesis of proteins at synaptic sites on dendrites: role in synaptic plasticity and memory consolidation? Neurobiol Learn Mem (2002) 1.36
Current advances in local protein synthesis and synaptic plasticity. J Neurosci (2006) 1.35
Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Mol Pharmacol (2000) 1.32
Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor. J Neurophysiol (2006) 1.29
Enhancement by an ampakine of memory encoding in humans. Exp Neurol (1997) 1.24
Synaptic plasticity in cortical systems. Curr Opin Neurobiol (1999) 1.19
AMPA receptor modulators as cognitive enhancers. Curr Opin Pharmacol (2004) 1.15
Genes to remember. J Exp Biol (1999) 1.13
Chronic elevation of brain-derived neurotrophic factor by ampakines. J Pharmacol Exp Ther (2003) 1.12
Brain-derived neurotrophic factor regulates the expression of AMPA receptor proteins in neocortical neurons. Neuroscience (1999) 1.10
Cytosolic Ca2+ changes during in vitro ischemia in rat hippocampal slices: major roles for glutamate and Na+-dependent Ca2+ release from mitochondria. J Neurosci (1999) 1.09
Involvement of the secretory pathway for AMPA receptors in NMDA-induced potentiation in hippocampus. J Neurosci (2001) 1.07
Control of synaptic consolidation in the dentate gyrus: mechanisms, functions, and therapeutic implications. Prog Brain Res (2007) 1.05
Heterosynaptic scaling of developing GABAergic synapses: dependence on glutamatergic input and developmental stage. J Neurosci (2007) 1.01
Brain-derived neurotrophic factor blocks long-term depression in rat visual cortex. J Neurophysiol (1996) 1.01
Brain-derived neurotrophic factor signal enhances and maintains the expression of AMPA receptor-associated PDZ proteins in developing cortical neurons. Dev Biol (2003) 0.98
Growth factor-mediated Fyn signaling regulates alpha-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor expression in rodent neocortical neurons. Proc Natl Acad Sci U S A (1999) 0.97
Control of kinetic properties of GluR2 flop AMPA-type channels: impact of R/G nuclear editing. Eur J Neurosci (2002) 0.97
AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression. J Neurochem (2004) 0.96
Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons. Neuropharmacology (2002) 0.96
Endogenous, Ca(2+)-dependent cysteine-protease cleaves specifically the ryanodine receptor/Ca2+ release channel in skeletal muscle. J Membr Biol (1994) 0.95
The role of intracellular Na+ and mitochondria in buffering of kainate-induced intracellular free Ca2+ changes in rat forebrain neurones. J Physiol (1998) 0.93
A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task. Synapse (1993) 0.90
Possible involvement of BDNF release in long-lasting synapse formation induced by repetitive PKA activation. Neurosci Lett (2006) 0.89
RNA editing (Q/R site) and flop/flip splicing of AMPA receptor transcripts in young and old brains. Neurobiol Aging (2000) 0.87
Development of calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured neocortical neurons visualized by cobalt staining. J Neurosci Res (1998) 0.81
In search of molecular memory: experience-driven protein synthesis. Cell Mol Life Sci (2000) 0.81
The lethal expression of the GluR2flip/GluR4flip AMPA receptor in HEK293 cells. Eur J Neurosci (2000) 0.81
S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures. Eur J Pharmacol (2007) 0.78
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
CREB regulates excitability and the allocation of memory to subsets of neurons in the amygdala. Nat Neurosci (2009) 2.60
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Theta stimulation polymerizes actin in dendritic spines of hippocampus. J Neurosci (2005) 1.85
Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci U S A (2003) 1.79
SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci (2010) 1.71
Calpain-mediated mGluR1alpha truncation: a key step in excitotoxicity. Neuron (2007) 1.61
Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 -/- mouse brain. Am J Pathol (2007) 1.46
The hippocampus plays a selective role in the retrieval of detailed contextual memories. Curr Biol (2010) 1.45
Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia. Exp Neurol (2003) 1.38
Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. J Neurosci (2006) 1.34
Brain-derived neurotrophic factor and epidermal growth factor activate neuronal m-calpain via mitogen-activated protein kinase-dependent phosphorylation. J Neurosci (2010) 1.33
Glutamatergic neurons in rodent models respond to nanoscale particulate urban air pollutants in vivo and in vitro. Environ Health Perspect (2011) 1.29
17-Beta-estradiol increases neuronal excitability through MAP kinase-induced calpain activation. Proc Natl Acad Sci U S A (2009) 1.24
Modeling glutamatergic synapses: insights into mechanisms regulating synaptic efficacy. J Integr Neurosci (2008) 1.19
Integrated multiscale modeling of the nervous system: predicting changes in hippocampal network activity by a positive AMPA receptor modulator. IEEE Trans Biomed Eng (2011) 1.12
Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration. J Neurosci (2013) 1.12
Chronic elevation of brain-derived neurotrophic factor by ampakines. J Pharmacol Exp Ther (2003) 1.12
Allopregnanolone treatment, both as a single injection or repetitively, delays demyelination and enhances survival of Niemann-Pick C mice. J Neurosci Res (2005) 1.12
Critical role of collapsin response mediator protein-associated molecule CRAM for filopodia and growth cone development in neurons. Mol Biol Cell (2004) 1.09
Ampakines promote spine actin polymerization, long-term potentiation, and learning in a mouse model of Angelman syndrome. Neurobiol Dis (2012) 1.08
Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors. Eur J Nucl Med Mol Imaging (2008) 1.08
Computational studies of NMDA receptors: differential effects of neuronal activity on efficacy of competitive and non-competitive antagonists. Open Access Bioinformatics (2010) 1.07
A novel function for p53: regulation of growth cone motility through interaction with Rho kinase. J Neurosci (2009) 1.05
A computational model to investigate astrocytic glutamate uptake influence on synaptic transmission and neuronal spiking. Front Comput Neurosci (2012) 1.04
Calpain-2-mediated PTEN degradation contributes to BDNF-induced stimulation of dendritic protein synthesis. J Neurosci (2013) 1.02
Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices. Eur J Neurosci (2009) 1.01
Lack of phenotype for LTP and fear conditioning learning in calpain 1 knock-out mice. Neurobiol Learn Mem (2005) 1.00
Metabotropic glutamate receptors and epilepsy. J Neurol Sci (2006) 1.00
Regulation of calpain-2 in neurons: implications for synaptic plasticity. Mol Neurobiol (2010) 1.00
Prevention of cognitive deficits and brain oxidative stress with superoxide dismutase/catalase mimetics in aged mice. Neurobiol Aging (2008) 0.99
17beta-estradiol modifies stress-induced and age-related changes in hippocampal synaptic plasticity. Behav Neurosci (2008) 0.98
Conditional disruption of calpain in the CNS alters dendrite morphology, impairs LTP, and promotes neuronal survival following injury. J Neurosci (2013) 0.97
Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-β. J Neurochem (2010) 0.97
17beta-estradiol-mediated neuroprotection and ERK activation require a pertussis toxin-sensitive mechanism involving GRK2 and beta-arrestin-1. J Neurosci (2009) 0.96
NMDA mediated contextual conditioning changes miRNA expression. PLoS One (2011) 0.96
Role of calpain-mediated p53 truncation in semaphorin 3A-induced axonal growth regulation. Proc Natl Acad Sci U S A (2010) 0.96
CRMP3 is required for hippocampal CA1 dendritic organization and plasticity. FASEB J (2007) 0.94
Deregulation of the phosphatidylinositol-3 kinase signaling cascade is associated with neurodegeneration in Npc1-/- mouse brain. Am J Pathol (2005) 0.94
Long-term recording of LTP in cultured hippocampal slices. Neural Plast (2002) 0.93
Allopregnanolone treatment delays cholesterol accumulation and reduces autophagic/lysosomal dysfunction and inflammation in Npc1-/- mouse brain. Brain Res (2009) 0.92
Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation. Exp Neurol (2009) 0.92
17-Beta-estradiol-mediated activation of extracellular-signal regulated kinase, phosphatidylinositol 3-kinase/protein kinase B-Akt and N-methyl-D-aspartate receptor phosphorylation in cortical synaptoneurosomes. J Neurochem (2007) 0.92
Fluorescence resonance energy transfer (FRET)-based biosensors: visualizing cellular dynamics and bioenergetics. Appl Microbiol Biotechnol (2012) 0.91
Effects of estrogen, age, and calpain on MAP kinase and NMDA receptors in female rat brain. Neurobiol Aging (2003) 0.91
Role for Fes/Fps tyrosine kinase in microtubule nucleation through is Fes/CIP4 homology domain. J Biol Chem (2003) 0.90
Abnormal gene expression in cerebellum of Npc1-/- mice during postnatal development. Brain Res (2010) 0.90
The biochemistry of memory: The 26year journey of a 'new and specific hypothesis'. Neurobiol Learn Mem (2010) 0.90
IgG-immunostaining in the intact rabbit brain: variable but significant staining of hippocampal and cerebellar neurons with anti-IgG. Brain Res (2002) 0.89
Cholesterol Perturbation in Mice Results in p53 Degradation and Axonal Pathology through p38 MAPK and Mdm2 Activation. PLoS One (2010) 0.88
AMPA receptor phosphorylation is selectively regulated by constitutive phospholipase A(2) and 5-lipoxygenase activities. Hippocampus (2005) 0.88
Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia. J Biol Chem (2004) 0.88
Estrogen and hippocampal plasticity in rodent models. J Alzheimers Dis (2008) 0.88
Prolonged positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors induces calpain-mediated PSD-95/Dlg/ZO-1 protein degradation and AMPA receptor down-regulation in cultured hippocampal slices. J Pharmacol Exp Ther (2005) 0.87
Regulation of hippocampal synaptic plasticity by estrogen and progesterone. Vitam Horm (2010) 0.87
Iron toxicity in organotypic cultures of hippocampal slices: role of reactive oxygen species. J Neurochem (2003) 0.87
RVG-mediated calpain2 gene silencing in the brain impairs learning and memory. Neuromolecular Med (2012) 0.85
Targeting calpain in synaptic plasticity. Expert Opin Ther Targets (2013) 0.85
Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. J Alzheimers Dis (2012) 0.85
Simulation of postsynaptic glutamate receptors reveals critical features of glutamatergic transmission. PLoS One (2011) 0.85
Learning and memory: an emergent property of cell motility. Neurobiol Learn Mem (2013) 0.84
Effects of positive AMPA receptor modulators on calpain-mediated spectrin degradation in cultured hippocampal slices. Neurochem Int (2005) 0.84
Rapid reduction of ATP synthesis and lack of free radical formation by MPP+ in rat brain synaptosomes and mitochondria. Brain Res (2003) 0.83
Lysosomes and brain aging in mammals. Neurochem Res (2003) 0.83
Ultrastructural analysis of hippocampal pyramidal neurons from apolipoprotein E-deficient mice treated with a cathepsin inhibitor. J Neurocytol (2004) 0.83
Maintenance of synaptic stability requires calcium-independent phospholipase A₂ activity. Neural Plast (2012) 0.83
Chronic multichannel recordings from organotypic hippocampal slice cultures: protection from excitotoxic effects of NMDA by non-competitive NMDA antagonists. J Neurosci Methods (2002) 0.82
Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences. Neuroscientist (2007) 0.82
Detection and classification of neurotoxins using a novel short-term plasticity quantification method. Biosens Bioelectron (2003) 0.82
Superoxide dismutase/catalase mimetics but not MAP kinase inhibitors are neuroprotective against oxygen/glucose deprivation-induced neuronal death in hippocampus. J Neurochem (2007) 0.82
EUK-207, a superoxide dismutase/catalase mimetic, is neuroprotective against oxygen/glucose deprivation-induced neuronal death in cultured hippocampal slices. Brain Res (2008) 0.81
Attenuation of zinc-induced intracellular dysfunction and neurotoxicity by a synthetic superoxide dismutase/catalase mimetic, in cultured cortical neurons. Brain Res (2002) 0.80
Influence of ionotropic receptor location on their dynamics at glutamatergic synapses. Conf Proc IEEE Eng Med Biol Soc (2012) 0.79
Estrogen and hippocampal synaptic plasticity. Neuron Glia Biol (2004) 0.79
Brain plasticity and remodeling of AMPA receptor properties by calcium-dependent enzymes. Genet Eng (N Y) (2004) 0.79
Paired-pulse stimulation at glutamatergic synapses - pre- and postsynaptic components. Conf Proc IEEE Eng Med Biol Soc (2010) 0.78
Calcium-independent phospholipase A(2) influences AMPA-mediated toxicity of hippocampal slices by regulating the GluR1 subunit in synaptic membranes. Hippocampus (2007) 0.78
Reduced early hypoxic/ischemic brain damage is associated with increased GLT-1 levels in mice expressing mutant (P301L) human tau. Brain Res (2008) 0.77